Human herpesvirus 8 (HHV-8), associated with the endothelial tumor Kaposi's sarcoma, encodes three CC/β-chemokines. These are expressed early during productive (lytic) infection and believed to be involved in immune evasion, in addition to viral pathogenesis via induction of angiogenic cytokines. Here we report that two of the HHV-8 chemokines, CCR8 agonists vCCL-1 and vCCL-2, have direct effects on endothelial survival and virus replication. 
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and pro-angiogenic cytokine viral interleukin-6 (vIL-6) in addition to the three HHV-8-specified viral chemokines, which also induce angiogenesis, may play important pathogenic roles (35) .
Vascular endothelial growth factor (VEGF), induced by vIL-6 (1) and at least one of the viral chemokines (25) , is believed to contribute to PEL also (2) . Therefore, study of the HHV-8 cytokines is relevant to understanding the mechanisms by which HHV-8 induces neoplasia and for developing therapeutic interventions. The roles of the v-cytokines in normal virus biology have not been defined, and indeed they may represent useful anti-viral targets.
HHV-8 CC/β-chemokines vCCL-1, vCCL-2 and vCCL-3 are encoded by open reading frames (ORFs) K6, K4 and K4.1, respectively. vCCL-2 binds to a broad range of CC-chemokine receptors and can also target CXCR4, CX 3 C and XCR1 (6, 10, 13, 16, 23, 29, 42, 45) . However, only CCR3 and CCR8 are able to support vCCL-2 signal transduction. vCCL-1 signals via CCR8 and vCCL-3 has been reported to be an agonist for CCR4 and XCR1 (13, 16, 28, 45, 47) .
The functions in virus biology of the HHV-8 v-chemokines remain speculative, but may include roles in immune evasion and virus dissemination via Th2 polarization and lymphocyte/monocyte recruitment mediated by their various agonist and neutral agonist activities (35) . However, their potential roles in promoting productive, or lytic, virus replication via direct effects on virus infected cells have not been investigated. In view of the previously demonstrated pro-survival activities of vCCL-1 and vCCL-2 on PEL cells (25) and vCCL-1 on murine thymic lymphoma cells (26, 46) , this is a distinct possibility, potentially enabling the Virus Production and Infection. Infectious HHV-8 virus was obtained by inducing BCBL-1 cells with phorbol 12-myristate 13-acetate (PMA, 20 ng/ml) and calcium ionophore (A23187, 500 ng/ml). After 16 to 20 h cells were pelleted and resuspended in fresh medium without PMA and A23187. After 5 days, cells were pelleted, the supernatant filtered through a 0.45 µm filters, and virions pelleted at 15,000 rpm for 2 h in an SW41 rotor. For infection of TIME cells, the viral pellet was resuspended in basal EGM  -2 MV medium supplemented with 5 µg of polybrene per ml and added to cell cultures for 2 h, prior to replacement of inoculum with fresh medium. For virus inductions, the medium was replaced (after >48 h) with fresh medium containing 20 ng/ml tetradecanoyl phorbol acetate (TPA). Lentiviruses were produced using calcium phosphate-mediated cotransfection of HEK293T cells with pYNC352-or pYNC320- ng/ml). The results confirmed specificity of signaling by the chemokines, with no activation of ERK in the negative controls (Fig.1B, lower section) .
A C C E P T E D
Treatment of DMVECs in addition to TIME cells with the v-chemokines and CCL1
(using maximally effective, matched doses), revealed chemokine-induced ERK and AKT activation in both cell types (Fig.1C) . The kinetics of ERK and AKT activation by vCCL-1, signaling was abrogated in the CCL1 pre-treated cells ( Fig.2A, top) . Non-CCR8 agonists CXCL1 (GROα) and lysophosphatidic acid (LPA) were, by contrast, able to signal normally in CCL1 pre-treated cultures ( Fig.2A, bottom) , demonstrating that effects on v-chemokine signaling were the result of homologous (receptor-specific) rather than heterologous desensitization.
To provide further evidence of v-chemokine utilization of and dependence on CCR8, signaling assays were undertaken in a TIME cell line, TIME-CCR8 i (E2), stably transduced with a lentiviral vector constitutively expressing CCR8 mRNA-specific shRNA. Quantitative RT-PCR for CCR8 mRNA and immunofluorescence assays (IFAs) to detect surface expression of CCR8 demonstrated RNA i efficacy in TIME-CCR8 i cells ( Together, the data from the desensitization and CCR8 knockdown experiments demonstrate that vCCL-1 and vCCL-2, like CCL1, operate through CCR8 in endothelial cells, and that other receptors are unlikely to be involved.
Viral Chemokines Protect Endothelial Cells From Starvation-Induced Apoptosis.
In consideration of previously reported anti-apoptotic activities of vCCL-1 and vCCL-2 on PEL and vCCL-1 on murine BW4157 thyoma cells (25, 26) , the v-chemokines were tested for their abilities to protect endothelial cells also. Apoptosis in TIME and DMVEC cultures was induced by serum deprivation, and annexin V-FITC staining ( Fig.3A ) was used to detect apoptosis after 48 h in the presence and absence of chemokine supplementation. For TIME cells (Fig.3B ), the v-chemokines and CCL1 conferred protection of around 40-60% relative to the untreated (PBS) and pTYB4-treated controls, very similar to the level of protection obtained using VEGF, a known endothelial cell survival factor (19, 36) . Significant protection of DMVECs also was mediated by each of the CCR8 agonists, and again, these were comparable with VEGF-mediated protection ( Fig.3C ). CCR8-depleted TIME-CCR8 i cells were refractory to the protective effects of vCCL-1, vCCL-2 and CCL1, but not VEGF, demonstrating that CCR8 was necessary for the pro-survival activities of the chemokines (Fig.3D) . Bim destabilization (24, 27) , is relevant here.
Also analyzed for expression was the anti-apoptotic protein Bcl-2, regulated positively by NF-κB, a target of AKT signaling that promotes NF-κB nuclear translocation and activation (31, 37) . In contrast to Bim, Bcl-2 levels were increased by the CCR8 agonists and VEGF (Fig.4D ).
Further investigation determined that Bcl-2 phosphorylation at Ser-70, associated with Bcl-2 activation, was induced by vCCL-1, vCCL-2 and CCL1 in a PD98059-sensitive [MEK (ERK kinase)-dependent] manner (Fig.4E ). ERK-targeting of serine and threonine residues in this loop region of Bcl-2 has been reported to regulate Bcl-2 stability and activity (5, 7) . Together, these data suggest that the anti-apoptotic effects of the v-chemokines and CCL1, in addition to VEGF, are in part mediated via suppression of pro-apoptotic Bim and may also involve induction and activation of Bcl-2.
HHV-8 v-Chemokines Inhibit Apoptosis Induced by HHV-8 Productive Replication.
Relevant to potential roles of the v-chemokines in promoting virus replication via survival signaling, we tested their effects on apoptosis induced during lytic replication. TIME cells were infected with BCBL-1 PEL cell-derived virus, and lytic cycle replication was then induced with TPA. Apoptosis was monitored at day-6 post-induction by TUNEL staining in the absence and presence of vCCL-1, vCCL-2 and CCL1, with latency-associated nuclear antigen (LANA) costaining performed to identify infected cells. The results (Fig.5A,B Further experiments were undertaken to investigate by qPCR the production of encapsidated (DNaseI resistant) viral genomes released into the medium over the course of ten days post-TPA-induction, allowing total virus yields to be determined. Consistent with the IFA results, we found markedly increased virus production in cells treated with the chemokines or VEGF relative to untreated controls (Fig.5D ). The cytokines had no effect on virus production in the absence of lytic induction by TPA (data not shown). In a separate experiment, Western individually and together, obtained in signal transduction assays (Fig.1B) .
A C C E P T E D
Autocrine Effects of v-Chemokines. To determine whether endogenously-produced HHV-8 chemokines could stimulate virus production via autocrine signaling, virus reactivation experiments were undertaken in TIME-CCR8 i cell lines and "pooled" transformants (uncloned).
This approach allowed assessment both of the functionality of normal, virus-produced concentrations of the v-chemokines and their effects on virus replication in the cells in which they were produced. CCR8 depletion in these experiments was functionally equivalent to a vCCL-1/vCCL-2 knockout virus. Western analysis of NS versus CCR8 shRNA-transduced cultures confirmed reduced CCR8 levels in the mixed cell population (Fig.6A) , similar to results obtained with CCR8 shRNA-expressing cell lines (Fig.2 , panels B and C). signaling inhibition (Fig.6B ). Cultures treated with TPA alone, in the absence of exogenously added chemokines, revealed CCR8 i -dependent differences, with CCR8-depleted cells showing markedly reduced virus production relative to NS-shRNA-transduced control cultures (Fig.6C ).
As no induction of CCL1 was identified, by qRT-PCR, in TPA (or TPA+vCCL-1/2) treated TIME cultures (results not shown), the data indicate that virus-produced vCCL-1 and/or vCCL-2 are able to promote virus replication in an autocrine manner.
The combined and individual roles of vCCL-1 and vCCL-2 in virus replication via autocrine signaling were verified and investigated through the generation of shRNAs for vCCL-1 and vCCL-2 knockdown. Initially, candidate shRNAs were tested for efficacy in transfected HEK293T cells (Fig.7A) , and the most active in protein depletion subsequently utilized in functional assays in TIME cells. Single and double vCCL-depleted cultures were generated via transduction of cells with drug-selectable lentiviral vectors encoding either NS (control) or vCCL-1 shRNA followed (after drug selection) by secondary high efficiency (>80%) transduction with GFP + lentiviral vectors specifying NS or vCCL-2 shRNA. HHV-8 reactivation from these cultures followed by qPCR of encapsidated viral DNA identified individual and combined effects of the v-chemokines on virus yields following 6 days of TPA treatment (Fig.6B) . Single depletion of vCCL-1 and vCCL-2 led to reduced yields of virus (around 60% of control), but this effect was markedly enhanced by combined knockdown of vCCL-1 and vCCL-2, which diminished virus production by approximately 80% (Fig.7B) . TUNEL analysis for detection of apoptosis in these cultures revealed increased cell death in the double-knockdown cells, although only modest effects of single vCCL depletion (Fig.7C) . We conclude that both vCCL-1 and vCCL-2 function to promote virus replication via autocrine signal transduction and that this may in part be mediated via promotion of cell survival. by vCCL-1 and CCL1 treatments of TIME-NS cells (Fig.8B, right panel) . TIME-CCR8 i cultures were reduced in numbers of Bim-positive cells expressing K8.1 antigen in the absence of chemokine, and were, as expected, essentially unresponsive to the CCR8 agonists, although not to VEGF. Together, these IFA data demonstrate a tight correlation between Bim expression and lytic reactivation, and indicate that v-chemokines signaling via CCR8 promotes lytic cycle progression in both autocrine and paracrine fashions.

Bim Suppression Mimics Pro-Replication Functions of HHV-8 Chemokines.
To correlate pro-survival activities of and Bim regulation by the v-chemokines with increased lytic replication induced by the CCR8 agonists, Bim-specific shRNA or NS-shRNA negative control were transduced by virus vector into TIME cells to generate (drug-selected) pooled cultures.
These were then infected with BCBL-1-derived virus and reactivation experiments undertaken as dramatically in the Bim-depleted cultures, but, notably, the effects of the cytokines were reduced in these cells relative to TIME-NS controls (Fig.8D ). Reflecting these data, virus production was enhanced greatly but effects of the v-chemokines, CCL1 and VEGF reduced in Bim-depleted cells relative to TIME-NS cultures (Fig.8E) . Together, the results indicate that the chemokines mediate their pro-replication functions, at least in part, via Bim repression, and that this enhances lytic cycle progression. homologue, vIL-6, also has been speculated to contribute to pathogenesis; like its cellular counterpart, it is both an angiogenic and an inflammatory cytokine. Unlike vGPCR, its contributions to pathogenesis would be independent of host shut-off functions. Thus, our work adds the viral chemokines vCCL-1 and vCCL-2 to the short list of HHV-8 lytic proteins that potentially could contribute to neoplasia via paracrine signaling. Uniquely, however, we also provide evidence for enhancement of lytic replication by the v-chemokines, by a mechanism that is likely to be mediated in part via pro-survival functions.
A C C E P T E D
DISCUSSION
The mechanisms of anti-apoptotic signaling by vCCL-1 and vCCL-2 in response to starvation and lytic replication in endothelial cells are not fully resolved, but our data suggest that regulation of Bim is important. Firstly, Bim, a key Bcl-2-family protein in the regulation of in TIME and TIME-CCR8 i (E2) cells, but reduced signaling in TIME-CCR8 i (E2) cells by CCR8 agonist CCL1, demonstrating the specificity of the CCR8-shRNA effect (bottom). 
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